Position in AZN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$2,933,231
-$209,864 QoQ
Shares Held
15,469
-2.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#464
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 17%
Shared 0%
None 83%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Verdence Capital Advisors LLC holds $47,881,370 across 14 Drug Manufacturers - General names. AZN ranks #7 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,223 | $8,663,483 | |
| 2 | JNJ |
Johnson & Johnson
|
31,901 | $8,101,896 | |
| 3 | ABBV |
AbbVie Inc.
|
27,419 | $6,899,717 | |
| 4 | MRK |
Merck & Co., Inc.
|
49,521 | $6,363,448 | |
| 5 | AMGN |
Amgen Inc
|
14,656 | $5,307,230 | |
| 6 | PFE |
Pfizer Inc
|
168,925 | $4,067,714 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
15,469 | $2,933,231 | |
| 8 | SNY |
Sanofi
|
46,110 | $1,967,052 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,933,231 | 15,469 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $3,143,095 | 15,937 | Shares | Sole | 2026-04-30 | |
| No filing history on record for this holder in this stock. | ||||||